Citation: M. Karlsson et al., AUTOMATED-ANALYSIS OF LEVOSIMENDAN IN HUMAN PLASMA BY ONLINE DIALYSISAND LIQUID-CHROMATOGRAPHY, BMC. Biomedical chromatography, 11(1), 1997, pp. 54-58
Citation: T. Wikberg et al., ENANTIOMERIC BIOANALYSIS OF SIMENDAN AND LEVOSIMENDAN BY CHIRAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Chirality, 8(7), 1996, pp. 511-517
Authors:
KERANEN T
GORDIN A
KOULU M
SCHEININ M
ANTILA S
SUNDBERG S
WIKBERG T
Citation: T. Keranen et al., COMT INHIBITION BY ENTACAPONE DOES NOT AFFECT GROWTH-HORMONE OR PROLACTIN SECRETION IN HEALTHY-VOLUNTEERS, Journal of neural transmission, 103(6), 1996, pp. 729-736
Authors:
AHTILA S
KAAKKOLA S
GORDIN A
KORPELA K
HEINAVAARA S
KARLSSON M
WIKBERG T
TUOMAINEN P
MANNISTO PT
Citation: S. Ahtila et al., EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS, Clinical neuropharmacology, 18(1), 1995, pp. 46-57
Citation: T. Wikberg et A. Vuorela, METABOLITE PROFILES OF 2 [C-14] LABELED CATECHOL O-METHYLTRANSFERASE INHIBITORS, NITECAPONE AND ENTACAPONE, IN RAT AND MOUSE URINE AND RAT BILE, European journal of drug metabolism and pharmacokinetics, 19(2), 1994, pp. 125-135
Authors:
KERANEN T
GORDIN A
KARLSSON M
KORPELA K
PENTIKAINEN PJ
RITA H
SCHULTZ E
SEPPALA L
WIKBERG T
Citation: T. Keranen et al., INHIBITION OF SOLUBLE CATECHOL-O-METHYLTRANSFERASE AND SINGLE-DOSE PHARMACOKINETICS AFTER ORAL AND INTRAVENOUS ADMINISTRATION OF ENTACAPONE, European Journal of Clinical Pharmacology, 46(2), 1994, pp. 151-157
Citation: T. Wikberg et al., IDENTIFICATION OF MAJOR URINARY METABOLITES OF THE CATECHOL-O-METHYLTRANSFERASE INHIBITOR ENTACAPONE IN THE DOG, European journal of drug metabolism and pharmacokinetics, 18(4), 1993, pp. 359-367